Regeneron Pharmaceuticals, Inc. (0R2M)
Market Closed
24 Feb, 15:30
$
777. 17
-9.81
-1.25%
$
- Market Cap
24.52 P/E Ratio
- Div Yield
323 Volume
42.79 Eps
$ 786.98
Previous Close Day Range
774.6 795.49
Year Range
689 998.57
Want to track 0R2M and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
0R2M earnings report is expected in 62 days (27 Apr 2026)
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | 9.16 | - |
| | | 9.16 | - |
| | | - | - |
| | | - | - |
| | | 10.64 | 7.86 |
| | | - | - |
| | | - | - |
0R2M Earnings Reports FAQ
What is the earnings per share (EPS) for 0R2M?
The current EPS is 42.79.
What is the company's earnings growth rate?
Regeneron Pharmaceuticals, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
The next earnings release is expected to be on 2026-04-27, based on the 0R2M's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings were 7.8567 per share, reported on 2026-01-30. For dividend history, visit the 0R2M Dividends page.
What is the price-to-earnings (P/E) ratio?
The price-to-earnings (P/E) ratio is 98.92, calculated based on the most recent stock price of $777.17.
